Chronic prostatitis is among the most common, and most frustrating, urologic conditions in men. For men with persistent pelvic discomfort, urinary urgency or pain with ejaculation, the search for non-antibiotic relief can be discouraging. This article reviews what the clinical literature shows about plant-based (phytotherapeutic) approaches to chronic prostatitis, how the 2025 American Urological Association (AUA) guideline positions them, and what to look for on a label.
The goal is not to overstate what supplements can do, but to give men and their clinicians an accurate, referenced basis for judging their options.
Disclosure: this article is published by Aleaf Labs, which makes Pro-UROL, one of the licensed products discussed below.
Understanding Chronic Prostatitis (CP/CPPS)
Modern urology uses the National Institutes of Health (NIH) classification, which divides prostatitis into four categories. Category III, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), accounts for the large majority of cases, and is subdivided into inflammatory (IIIA) and non-inflammatory (IIIB) types.1
CP/CPPS is defined by pelvic or perineal pain lasting at least three months, often with urinary symptoms and sexual dysfunction, with no infection found.1 Epidemiologic reviews estimate that roughly 2% to 10% of men are affected worldwide.2 For the full picture of symptoms, diagnosis and conditions that mimic it, see non-bacterial prostatitis explained.
Trials measure symptoms with the NIH Chronic Prostatitis Symptom Index (NIH-CPSI), a nine-item questionnaire covering pain, urinary symptoms and quality of life, scored 0 to 43.3 A drop of about 6 points is the best threshold for an improvement men notice.
Why Antibiotics Often Fall Short
Because CP/CPPS has no consistent infectious cause, antibiotics often fail to give lasting relief. A Cochrane review of drug treatments found that antibiotics, alpha-blockers and anti-inflammatories each produce, at best, small reductions in symptom scores.4 That is why management has shifted toward a multimodal approach matched to each man's symptoms, in which plant-based treatments are one option among several.
The Evidence for Phytotherapy
In April 2025 the AUA released its first dedicated guideline on male chronic pelvic pain. It states that in patients with CP/CPPS, "clinicians may prescribe phytotherapeutics including saw palmetto, quercetin, and pollen extract to improve pain, voiding symptoms, and quality of life" (Conditional Recommendation; Evidence Grade B).5 "May" is the AUA's conditional wording: it allows clinicians to consider these ingredients, names ingredients rather than products, and does not place them ahead of physiotherapy, shockwave therapy or an alpha-blocker. The European Association of Urology guideline similarly treats phytotherapy as a reasonable option within broader management.6
Pooled together, a Cochrane review of seven phytotherapy trials (551 men) found an average NIH-CPSI improvement of about 5 points versus placebo, with no clear increase in side effects. The review rated that evidence low certainty.4 The individual agents differ considerably.
Quercetin
Quercetin, a plant flavonoid, has one positive randomized controlled trial in CP/CPPS. Shoskes and colleagues randomized 30 men with Category III CP/CPPS to quercetin 500 mg twice daily or placebo for one month.7 Mean NIH symptom scores improved from 21.0 to 13.1 on quercetin versus 20.2 to 18.8 on placebo (P = 0.003), and 67% of men on quercetin improved by at least 25%, compared with 20% on placebo.7 The trial was small and short, and has not been repeated at larger scale.
Laboratory studies suggest why it might work. Quercetin inhibits NF-κB, the switch for many inflammatory signals, and suppresses COX-2 and lipoxygenase activity. It stabilizes mast cells, is an antioxidant in a condition where oxidative stress is elevated,10 and blocks TRPV1 pain channels. These are mechanisms seen in the lab, not evidence of benefit in men.
Pollen Extract
Pollen extracts, particularly Cernilton, made from rye-grass pollen, are among the more rigorously studied botanicals for CP/CPPS. In a multicentre, randomized, double-blind, placebo-controlled phase 3 trial, Wagenlehner and colleagues gave 139 men with inflammatory (IIIA) CP/CPPS Cernilton or placebo for 12 weeks.8 Pain, quality of life and total scores improved significantly more on pollen extract, and 70.6% responded versus 50.0% on placebo, with only minor side effects.8 The trial covered only the inflammatory subtype and used one branded extract, so its result does not transfer automatically to other pollen extracts.
Saw Palmetto
Although saw palmetto appears in the AUA's list, its CP/CPPS evidence is weak. In a one-year trial against finasteride, Kaplan and colleagues found no meaningful symptom benefit from saw palmetto in men with Category III prostatitis.9 A guideline list reflects available options, not equal efficacy. Be wary of CP/CPPS products that rely mainly on saw palmetto.
Proteolytic Enzymes (Bromelain and Papain)
Bromelain (from pineapple stem) and papain (from papaya) are included in some CP/CPPS formulas for their anti-inflammatory activity and possible effect on quercetin absorption. No randomized CP/CPPS trial has tested them, so their contribution is theoretical. They carry bleeding and allergy cautions.
A Note on Zinc
Zinc is often mentioned for prostate health because of its high concentration in prostatic fluid. Direct evidence that oral zinc improves CP/CPPS symptoms is thin and largely mechanistic.
Evidence That Is Often Misapplied
- BPH trials are not CP/CPPS trials. Saw palmetto, pygeum, nettle root, pumpkin seed and beta-sitosterol are studied mainly for urinary flow in older men with enlarged prostates. A product built on them may suit BPH; that does not show it relieves pelvic pain.
- Bacterial prostatitis trials are not CP/CPPS trials. An often-quoted Italian study combined supplements with an antibiotic in men with chronic bacterial prostatitis. Its results do not apply to CP/CPPS.
- An ingredient trial is not a product trial. A result for one branded extract at one dose does not prove a different product works.
How Long to Try a Supplement
The positive trials lasted 4 and 12 weeks. Note your NIH-CPSI score before starting, give a supplement about 12 weeks, and score again. If it has not fallen by roughly 6 points, the supplement is probably not doing enough to justify the cost, and it is worth discussing other options with your doctor.
What to Look for in a Supplement
- Ingredients with CP/CPPS trial data. Quercetin and pollen extract have the strongest randomized evidence.7,8
- Fully disclosed doses. The label should state each medicinal ingredient per tablet and how many tablets make a daily dose. A "proprietary blend" makes the dose impossible to compare with the trials.
- Extract details. For botanicals, look for an extract ratio or standardization, and ideally the source.
- An NPN. In Canada, a Natural Product Number means Health Canada reviewed the product's ingredients, dose, claims and warnings before licensing it. It does not require a trial of the finished product, and it does not make one licensed product better than another. You can look up any NPN in Health Canada's Licensed Natural Health Products Database.
Licensed Options in Canada
These products carry a Health Canada licensed claim for the pain of non-bacterial chronic prostatitis. Amounts are from each product's licence record, checked 29 September 2026. The list is not exhaustive.
| Product | NPN | Medicinal ingredients per daily dose | Note |
|---|---|---|---|
| Pro-UROL (Aleaf Labs) | 80147704 | Quercetin 1,200 mg; pollen extract 360 mg (10:1); bromelain 100 mg; papain 150 mg (3 tablets) | Highest quercetin and pollen amounts of the four |
| Urolo-Q (Searchlight Pharma) | 80039114 | About 960 mg quercetin (as dihydrate); pollen extract 88 mg (20:1); bromelain 50 mg; papain 100 mg; calcium carbonate (2 tablets) | Same four ingredients; on the market since 2013; fuller licensed warnings |
| NOW Quercetin with Bromelain | 80039849 | Quercetin dihydrate 800 mg; bromelain 165 mg (2 capsules) | No pollen extract |
| AOR Prostate Support | 80045408 | Pollen extract 138 mg (20:1) (3 capsules, per licence record) | Pollen only; also licensed for BPH night-time urination |
See Pro-UROL vs. Urolo-Q for a detailed comparison, and Pro-UROL for chronic prostatitis for its full licence record, dose-by-dose evidence and safety notes.
When to See a Clinician
Supplements are not a substitute for medical evaluation. See a doctor promptly for fever, blood in the urine or semen, inability to urinate, or a sudden worsening of symptoms, which can signal infection, obstruction or other problems. CP/CPPS is a diagnosis of exclusion, so an accurate diagnosis should come before any long-term self-management. Ask your pharmacist about interactions if you take blood thinners, anti-inflammatories or antibiotics.
Conclusion
Chronic prostatitis has no single reliable cure, but the options are better defined than many men realize. Quercetin and pollen extract each have one positive randomized trial and conditional guideline support. The evidence is modest and rests on ingredients, not finished products. The practical priorities: get diagnosed, choose products with trial-studied ingredients and disclosed doses, measure your symptoms, and reassess at about 12 weeks.
References
- Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–237.
- Krieger JN, Lee SWH, Jeon J, et al. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008;31(Suppl 1):S85–S90.
- Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health Chronic Prostatitis Symptom Index. J Urol. 1999;162(2):369–375.
- Franco JVA, Turk T, Jung JH, et al. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev. 2019;10:CD012552.
- Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part II — Treatment of CP/CPPS. J Urol. 2025;214(2):127–137.
- Fall M, Baranowski AP, Elneil S, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35–48.
- Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis. Urology. 1999;54(6):960–963.
- Wagenlehner FME, Schneider H, Ludwig M, et al. A pollen extract (Cernilton) in patients with inflammatory CP/CPPS: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol. 2009;56(3):544–551.
- Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/CP/CPPS. J Urol. 2004;171(1):284–288.
- Kullisaar T, Türk S, Punab M, et al. Oxidative stress in leucocytospermic prostatitis patients. Int J Androl. 2008;31(5):495–502.
This article is for general education and is not medical advice. Pro-UROL is licensed by Health Canada (NPN 80147704) to help relieve the pain of non-bacterial chronic prostatitis. The studies cited evaluated individual ingredients, not Pro-UROL as a finished product. Men with urologic symptoms should see a qualified health professional for diagnosis and care.